Perspectives on integrated continuous bioprocessing—opportunities and challenges
Tài liệu tham khảo
Kreps, 1938
Bertrams, 2013
Stephanopoulos, 2011, Process systems engineering: from Solvay to modern bio- and nanotechnology. A history of development, successes and prospects for the future, Chem Eng Sci, 66, 4272, 10.1016/j.ces.2011.05.049
Walthe, 2015, The business impact of an integrated continuous biomanufacturing platform for recombinant protein production, J Biotechnol
Hammerschmidt, 2014, Economics of recombinant antibody production processes at various scales: industry-standard compared to continuous precipitation, Biotechnol J, 9, 766, 10.1002/biot.201300480
Pacis, 2011, Effects of cell culture conditions on antibody N-linked glycosylation—what affects high mannose 5 glycoform, Biotechnol Bioeng, 108, 2348, 10.1002/bit.23200
Liu, 2008, Heterogeneity of monoclonal antibodies, J Pharm Sci, 97, 2426, 10.1002/jps.21180
Joshi, 2014, Avoiding antibody aggregation during processing: establishing hold times, Biotechnol J, 9, 1195, 10.1002/biot.201400052
Gillespie, 2012, Cation exchange surface-mediated denaturation of an aglycosylated immunoglobulin (IgG1), J Chromatogr A, 1251, 101, 10.1016/j.chroma.2012.06.037
Gospodarek, 2014, Unfolding of a model protein on ion exchange and mixed mode chromatography surfaces, J Chromatogr A, 1355, 238, 10.1016/j.chroma.2014.06.024
Guo, 2014, Unfolding and aggregation of a glycosylated monoclonal antibody on a cation exchange column. Part II. Protein structure effects by hydrogen deuterium exchange mass spectrometry, J Chromatogr A, 1356, 129, 10.1016/j.chroma.2014.06.038
Advancing Regulatory Science at FDA: A Strategic Plan. http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719.htm.
Woodcock, 2014, Modernizing pharmaceutical manufacturing—continuous manufacturing as a key enabler
Jungbauer, 2013, Continuous downstream processing of biopharmaceuticals, Trends Biotechnol, 31, 479, 10.1016/j.tibtech.2013.05.011
Rathore, 2015, Continuous processing for production of biopharmaceuticals, Prep Biochem Biotechnol, 45, 836, 10.1080/10826068.2014.985834
Zydney, 2015, Continuous downstream processing for high value biological products—a review, Biotechnol Bioeng, 10.1002/bit.25695
Arathoon, 1986, Large-scale cell culture in biotechnology, Science, 232, 1390, 10.1126/science.2424083
Warnock, 2006, Bioreactor systems for the production of biopharmaceuticals from animal cells, Biotechnol Appl Biochem, 45, 1, 10.1042/BA20050233
Hernandez, 2015, Continuous manufacturing: a changing processing paradigm, Biopharm Int, 28, 20
Voisard, 2003, Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells, Biotechnol Bioeng, 82, 751, 10.1002/bit.10629
Deo, 1996, Practical considerations in operation and scale-up of spin-filter based bioreactors for monoclonal antibody production, Biotechnol Prog, 12, 57, 10.1021/bp950079p
Carstensen, 2012, In situ product recovery: submerged membranes vs. external loop membranes, J Membrane Sci, 394, 1, 10.1016/j.memsci.2011.11.029
Kelly, 2014, Understanding and modeling alternating tangential flow filtration for perfusion cell culture, Biotechnol Prog, 30, 1291, 10.1002/btpr.1953
Cramer, 2011, Downstream bioprocessing: Recent advances and future promise, Curr Opin Chem Eng, 1, 27, 10.1016/j.coche.2011.08.008
Godawat, 2012, Periodic counter-current chromatography—design and operational considerations for integrated and continuous purification of proteins, Biotechnol J, 12, 1496, 10.1002/biot.201200068
Aniceto, 2015, Simulated moving bed strategies and designs: from established systems to the latest developments, Sep Purif Rev, 44, 41, 10.1080/15422119.2013.851087
Aumann, 2007, A continuous multicolumn countercurrent solvent gradient purification (MCSGP) process, Biotechnol Bioeng, 98, 1043, 10.1002/bit.21527
Uretschlager, 2002, Preparative continuous annular chromatography (P-CAC), a review, Bioprocess Biosyst Eng, 25, 129, 10.1007/s00449-002-0282-0
Lay, 2006, Continuous radial flow chromatography of proteins, Food Bioprod Proc, 84, 78, 10.1205/fbp.05156
Dutta, 2015, Purification of monoclonal antibodies from clarified cell culture fluid using protein A capture continuous countercurrent tangential chromatography, J Biotechnol, 10.1016/j.jbiotec.2015.02.026
Zang, 2011, Towards protein crystallization as a process step in downstream processing of therapeutic antibodies: screening and optimization at microbatch scale, PLoS ONE, 6, 1, 10.1371/journal.pone.0025282
Espitia-Saloma, 2014, Continuous aqueous two-phase systems devices for the recovery of biological products, Food Bioprod Process, 92, 101, 10.1016/j.fbp.2013.05.006
Alvarez, 2010, Continuous plug flow crystallization of pharmaceutical compounds, Cryst Growth Des, 10, 2219, 10.1021/cg901496s
Van Reis, 2007, Bioprocess membrane technology, J Membrane Sci, 297, 16, 10.1016/j.memsci.2007.02.045
Peeva, 2014, Continuous purification of active pharmaceutical ingredients using multistage organic solvent nanofiltration membrane cascade, Chem Eng Sci, 116, 183, 10.1016/j.ces.2014.04.022
Dizon-Maspat, 2012, Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production, Biotechnol Bioeng, 109, 962, 10.1002/bit.24377
Weisselberg, 2013
Miesegaes, 2010, Analysis of viral clearance unit operations for monoclonal antibodies, Biotechnol Bioeng, 106, 238
Warikoo, 2012, Integrated continuous production of recombinant therapeutic proteins, Biotechnol Bioeng, 109, 3018, 10.1002/bit.24584
Croughan, 2015, The future of industrial bioprocessing: batch of continuous?, Biotechnol Bioeng, 112, 648, 10.1002/bit.25529
Farid, 2014, Continuous bioprocessing: the real thing this time?, mAbs, 66, 1357, 10.4161/mabs.36151
Konstantinov, 2015, White paper on continuous bioprocessing. May 20–21, 2014. Continuous manufacturing symposium, J Pharm Sci, 104, 813, 10.1002/jps.24268